BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 11726579)

  • 1. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility.
    Omland AK; Fedorcsák P; Storeng R; Dale PO; Abyholm T; Tanbo T
    Hum Reprod; 2001 Dec; 16(12):2587-92. PubMed ID: 11726579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro fertilization in completely natural cycles.
    Fahy UM; Cahill DJ; Wardle PG; Hull MG
    Hum Reprod; 1995 Mar; 10(3):572-5. PubMed ID: 7782434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis.
    Al-Azemi M; Bernal AL; Steele J; Gramsbergen I; Barlow D; Kennedy S
    Hum Reprod; 2000 Jan; 15(1):72-5. PubMed ID: 10611191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis-associated or unexplained infertility: a controlled comparison with tubal infertility and use of donor spermatozoa.
    Hull MG; Williams JA; Ray B; McLaughlin EA; Akande VA; Ford WC
    Hum Reprod; 1998 Jul; 13(7):1825-30. PubMed ID: 9740433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility.
    Omland AK; Abyholm T; Fedorcsák P; Ertzeid G; Oldereid NB; Bjercke S; Tanbo T
    Hum Reprod; 2005 Mar; 20(3):722-7. PubMed ID: 15591078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infertility treatment by in vitro fertilization in patients with minimal or mild endometriosis.
    Meden-Vrtovec H; Tomazevic T; Verdenik I
    Clin Exp Obstet Gynecol; 2000; 27(3-4):191-3. PubMed ID: 11214948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility.
    Cahill DJ; Wardle PG; Harlow CR; Hull MG
    Hum Reprod; 1996 Mar; 11(3):647-50. PubMed ID: 8671284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer.
    Yamashita Y; Ueda M; Takehara M; Yamashita H; Suzuki Y; Hung YC; Terai Y; Ueki M
    Fertil Steril; 2002 Oct; 78(4):865-71. PubMed ID: 12372470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian dysfunction in endometriosis-associated and unexplained infertility.
    Cahill DJ; Wardle PG; Maile LA; Harlow CR; Hull MG
    J Assist Reprod Genet; 1997 Nov; 14(10):554-7. PubMed ID: 9447453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis.
    Tanbo T; Omland A; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):539-43. PubMed ID: 7618453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fertilization in spontaneous cycles--our experience.
    Bauman R; Mihaljević D; Kupesić S; Kurjak A
    Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):184-7. PubMed ID: 11950488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase oestradiol and progesterone levels are stronger predictors than follicular phase follicle stimulating hormone for the outcome of in-vitro fertilization treatment in women with tubal infertility.
    Csemiczky G; Wramsby H; Landgren BM
    Hum Reprod; 1996 Nov; 11(11):2396-9. PubMed ID: 8981118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program.
    Arici A; Oral E; Bukulmez O; Duleba A; Olive DL; Jones EE
    Fertil Steril; 1996 Mar; 65(3):603-7. PubMed ID: 8774295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of endometriosis on implantation. Data from the Wilford Hall Medical Center IVF-ET Program.
    Hickman TN
    J Reprod Med; 2002 Oct; 47(10):801-8. PubMed ID: 12418061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fertilization is a successful treatment in endometriosis-associated infertility.
    Opøien HK; Fedorcsak P; Omland AK; Abyholm T; Bjercke S; Ertzeid G; Oldereid N; Mellembakken JR; Tanbo T
    Fertil Steril; 2012 Apr; 97(4):912-8. PubMed ID: 22341637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis.
    Oehninger S; Acosta AA; Kreiner D; Muasher SJ; Jones HW; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):249-56. PubMed ID: 3148021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.